Immediate Impact
61 standout
Citing Papers
Targeted protein degradation: from mechanisms to clinic
2024 Standout
Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation
2023 Standout
Works of Toshiya Ito being referenced
Discovery of novel tetracyclic compounds as anaplastic lymphoma kinase inhibitors
2011
Design and synthesis of a highly selective, orally active and potent anaplastic lymphoma kinase inhibitor (CH5424802)
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Toshiya Ito | 131 | 187 | 226 | 147 | 26 | 421 | |
| Mar Abad | 80 | 215 | 119 | 168 | 25 | 471 | |
| Sadaaki Inutsuka | 105 | 177 | 128 | 148 | 21 | 441 | |
| Toru Hanamura | 61 | 147 | 118 | 196 | 38 | 488 | |
| Avram Walts | 100 | 213 | 139 | 106 | 14 | 508 | |
| Akiko Fukuhara | 35 | 167 | 178 | 142 | 24 | 463 | |
| Alex Y. C. Chang | 46 | 129 | 87 | 169 | 24 | 422 | |
| Roy Elias | 52 | 160 | 135 | 186 | 39 | 396 | |
| Yuichiro Kido | 120 | 107 | 81 | 197 | 30 | 413 | |
| Yueqing Tang | 94 | 202 | 95 | 96 | 19 | 438 | |
| J. Carmichael | 47 | 203 | 84 | 242 | 23 | 469 |
All Works
Login with ORCID to disown or claim papers
Loading papers...